The performance of the Australian equities market this year has highlighted, once again, a persistent conundrum facing ...

Bapcor ( ASX: BAP) downgraded earnings guidance again, with the core trade business to blame. The company now expects fiscal ...

For the past five years, Mark and Shani have released a weekly podcast and written on morningstar.com.au to arm you with the tools to invest successfully. They’ve always strived to provide independent ...

Semiliquid funds bypass capital calls and drawdown delays, giving investors direct exposure to private markets while ...

Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate ...

The Fund seeks to achieve its objective by tracking the performance of the MSCI Australia IMI Diversified Multiple-Factor Index (referred to in this section 5 of the PDS as the Index). We believe that ...

Bendigo struggles to compete with the four major banks because of their size, cost advantages, market presence, and ...

The market for GLP-1 drugs is projected to reach $180 billion in 2034, according to Morningstar Equity Research. Current ...

‘Save more’ turns into ‘Cut back on Ubers on a night out and instead use public transport. Save an extra $300 a month’.

Shares Bitcoin Trust ETF gained over 46% per year since inception, but the average dollar made only 11% annually.

The Vanguard Australian Shares High Yield ( ASX: VHY) strategy continues to be a dependable pick for investors seeking passive exposure to a portfolio of high-dividend-yielding Australian equities.

The objective of the Fund is to outperform the Benchmark net of fees and expenses over rolling 5 year periods. The investment objective & strategy is a summary of the investment's principal strategy ...